The world's leading eCOA solution just got a boost: Signant's flagship TrialMax® platform now leverages intelligent automation and operational enhancements to accelerate study builds by 33% or more, even for the most complex protocols.
TrialMax®: Now With Enhanced Acceleration
Complexity and Quality,
Delivered at Speed and Scale
Discover how these latest enhancements accelerate eCOA study delivery without compromising quality and functionality.
Smarter, Faster Study Builds
Innovative technology automation tools condense study build and testing processes from weeks into days without risk of errors. The result is 33% faster study launches, even for the most complex studies.
Efficient Scale Management
Our instrument library already includes hundreds of pre-validated, commonly used study scales and translations. When additional scales or translations are needed, our new automation tools accelerate scale management including translations and validation.
Unmatched Science, Scale, & Service
As always, TrialMax is delivered with the unrivaled scientific expertise, global operational reach, and comprehensive, attentive services customers have come to expect for nearly 25 years.
Enhanced Study Management
Additional, forthcoming efficiency enhancements will accelerate post-implementation support for reporting, analytics, and data change management.
25 Years of eCOA Experience
2,500+
STUDIES
95+
LANGUAGES
89
INDICATIONS
1.4M+
PATIENTS
2,600+
SCALES
198,000+
SITES
Want to learn more?
Get in touch with us to learn more about the industry's most robust, customizable eCOA platform, TrialMax, now delivering faster study launches for even the most complex trial designs.